Chromadex Corp Shares Approach 52-Week Low - Market Mover

The shares closed 0.3% above its 52-week low of $3.30, with trading volume higher than its 30 day average

Jan 10, 2022 by Kwhen Finance Editors

Chromadex Corp Shares Approach 52-Week Low - Market Mover
Chromadex Corp (CDXC) shares closed today at 0.3% above its 52 week low of $3.30, giving the company a market cap of $226M. The stock is currently down 11.5% year-to-date, down 31.5% over the past 12 months, and down 9.8% over the past five years. This week, the Dow Jones Industrial Average fell 0.3%, and the S&P 500 fell 1.9%.

Trading Activity

  • Trading volume this week was 86.5% higher than the 20-day average.
  • Beta, a measure of the stock’s volatility relative to the overall market stands at -0.1.

Technical Indicators

  • The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.
  • MACD, a trend-following momentum indicator, indicates a downward trend.
  • The stock closed above its Bollinger band, indicating it may be overbought.

Market Comparative Performance

  • The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis
  • The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis
  • The company share price is the same as the performance of its peers in the Materials industry sector , lags it on a 1-year basis, and lags it on a 5 year basis
NameDoD %ΔYTD %Δ1 Yr %52-Week H %52-Week L %
Chromadex Corp-4.3-11.5-31.5-85.25.8
Dow Jones Industrial Average-0.0-0.318.5-2.023.2
S&P 500 Index-0.4-1.923.9-2.528.8
Materials0.5-0.317.2-3.029.2

Peer Group Comparative Performance

  • The company's stock price performance year-to-date lags the peer average by 956.6%
  • The company's stock price performance over the past 12 months lags the peer average by 22.1%
NameMKT CAP (USD)P/EYTD %Δ1 Yr %Δ52-Week H %52-Week L %
Chromadex CorpCDXC0-11.5-31.5-85.25.8
Peer AvgN/A10.2-1.1-25.8-40.915.1
Exelixis IncEXEL36.12.5-17.9-28.419.1
Sangamo Therapeutics IncSGMO-5.4-9.7-60.1-60.110.1
Natural Alternatives International, Inc.NAII04.00.7-34.316.3

This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.

Was this content valuable for you?

Tags: